Fw: Hot Topics at The Body’s “Ask the Experts” ForumsFebruary 22, 2011
Zinc Fingers and Gene Therapies for HIV: Mimicking the Cured Berlin Patient?March 6, 2011
This will make it possible for GSK-ViiV to market their new Trii formulation of the new integrase inhibitor GSK572 (generic name: dolutegravir) plus Epzicom (abacavir plus epivir) as a once a day pill for naive patients
It contradicts all the previous studies that said that abacavir (Ziagen) causes increased cardiovascular risks.
GSK is currently enrolling studies to get dolutegravir approved. This drug may have activity against HIV with raltegravir resistance. More on this soon.